share_log
Reuters ·  12/03 07:30

Accord Biopharma Announces Agreement by Intas Pharmaceuticals, Ltd. to Acquire Udenyca® (Pegfilgrastim-Cbqv) Business From Coherus BioSciences, Inc., Unlocking Potential for Continued U.S. Growth

Accord生物制药宣布,Intas制药有限公司将收购Udenyca®(Pegfilgrastim-Cbqv)业务,从Coherus BioSciences公司,为继续美国增长释放潜力

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发